Together, these results indicate that in AML cell lines, PF-3758309 inhibited the kinases PAK, RPS6KAs, AMPK, PKA, CLKs and PHKG2 directly, whereas ROCKs, PKC and CDK5L were reduced as a downstream knock-on effect. The gene discussed is PRKAA1; the disease is acute myeloid leukemia.